Ditchcarbon
  • Contact
  1. Organizations
  2. César Castillo, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

César Castillo, Inc.

Company website

César Castillo, Inc., a prominent player in the pharmaceutical and healthcare distribution industry, is headquartered in the United States. Founded in 1975, the company has established a strong presence across various operational regions, including Puerto Rico and the Caribbean. Specialising in the distribution of pharmaceutical products, medical supplies, and healthcare solutions, César Castillo, Inc. is recognised for its commitment to quality and customer service. The company’s unique approach combines extensive industry knowledge with a robust logistics network, ensuring timely delivery of essential products. With decades of experience, César Castillo, Inc. has achieved significant milestones, positioning itself as a trusted partner for healthcare providers. Its dedication to innovation and excellence has solidified its reputation within the market, making it a leader in the pharmaceutical distribution sector.

DitchCarbon Score

How does César Castillo, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

César Castillo, Inc.'s score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

61%

Let us know if this data was useful to you

César Castillo, Inc.'s reported carbon emissions

In 2024, César Castillo, Inc. reported total carbon emissions of approximately 5,114,706,000 kg CO2e for Scope 1, 18,524,000 kg CO2e for Scope 2, and 107,500 kg CO2e for Scope 3. This reflects a significant increase in Scope 1 emissions compared to 2023, where emissions were about 4,459,942,000 kg CO2e, and Scope 2 emissions were approximately 23,097,000 kg CO2e, with Scope 3 emissions at 592,000 kg CO2e. The company has shown a progressive increase in emissions over the years, with Scope 1 emissions rising from about 3,578,316,000 kg CO2e in 2022 and Scope 2 emissions from approximately 66,304,000 kg CO2e. Notably, there is no reported data for Scope 3 emissions in 2022, indicating a potential area for future reporting and improvement. César Castillo, Inc. has not established specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from any parent organisation, ensuring that the reported figures are solely reflective of its own operations. Overall, while César Castillo, Inc. has made strides in emissions reporting, the lack of reduction commitments highlights an opportunity for the company to enhance its climate strategy and align with industry standards for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
3,578,316,000
0,000,000,000
0,000,000,000
Scope 2
66,304,000
00,000,000
00,000,000
Scope 3
-
000,000
000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. César Castillo, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for César Castillo, Inc. is in US, which has a high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

César Castillo, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251018.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy